GlassScriptPhysician profile
Hamed Bayat
NPI 1356344196
$5,907.95
in general payments reported to CMS, 2019-2025
31 companies · $740 in 2025
The $740 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,274 · 2020: $220 · 2021: $593 · 2022: $907 · 2023: $1,279 · 2024: $896 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,914.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,023.35 | 2019-2025 | Amvia Edge, Orsiro Mission, Pantera Leo |
| Abbott Laboratories | $630.61 | 2019-2024 | Mitraclip, Pressurewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $426.84 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $365.71 | 2022-2025 | |
| Pfizer INC. | $250.21 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $222.50 | 2019-2022 | |
| Boston Scientific Corporation | $203.36 | 2019-2022 | |
| Baxter Healthcare | $165.28 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Braemar Manufacturing, LLC | $162.31 | 2019 | |
| Abiomed | $160.85 | 2024-2025 | Impella |
| Kestra Medical Technology Services, INC. | $154.14 | 2023-2025 | Assure Wcd |
| Heartflow, INC. | $128.19 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.86 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $91.39 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $91.03 | 2022-2025 | Repatha, Repatha |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $89.19 | 2022-2024 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $85.13 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $79.53 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $74.74 | 2019-2021 | |
| Philips North America LLC | $65.01 | 2023-2025 | (Ck4) Mcot, Extended Holter |
| Edwards Lifesciences Corporation | $43.14 | 2021 | |
| Angiodynamics, INC. | $41.80 | 2023 | Angiovac |
| Kiniksa Pharmaceuticals, LTD. | $41.62 | 2022-2023 | Arcalyst |
| Otsuka America Pharmaceutical, INC. | $37.47 | 2019 | |
| Medtronic, INC. | $35.45 | 2022 | |
| Irhythm Technologies, INC. | $34.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.45 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $23.39 | 2022 | |
| Medtronic Vascular, INC. | $23.21 | 2019 | |
| Cardiva Medical, INC. | $20.60 | 2022 | |
| Cvrx, INC. | $17.43 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamed Bayat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.